These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36306339)

  • 21. ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
    Bonnez Q; Sakai K; Vanhoorelbeke K
    J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura.
    Thomas MR; de Groot R; Scully MA; Crawley JT
    EBioMedicine; 2015 Aug; 2(8):942-52. PubMed ID: 26425702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co(III)-NTA Mediated Antigen Immobilization on a Fiber Optic-SPR Biosensor for Detection of Autoantibodies in Autoimmune Diseases: Application in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
    Horta S; Qu JH; Dekimpe C; Bonnez Q; Vandenbulcke A; Tellier E; Kaplanski G; Delport F; Geukens N; Lammertyn J; Vanhoorelbeke K
    Anal Chem; 2020 Oct; 92(20):13880-13887. PubMed ID: 32929962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan.
    Matsumoto M; Fujimura Y; Wada H; Kokame K; Miyakawa Y; Ueda Y; Higasa S; Moriki T; Yagi H; Miyata T; Murata M;
    Int J Hematol; 2017 Jul; 106(1):3-15. PubMed ID: 28550351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical consult: aHUS, TTP? How to distinguish and what to do.
    Story CM; Gerber GF; Chaturvedi S
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):745-753. PubMed ID: 38066937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-glycan-mediated shielding of ADAMTS13 prevents binding of pathogenic autoantibodies in immune-mediated TTP.
    Ercig B; Graça NAG; Kangro K; Arfman T; Wichapong K; Hrdinová J; Kaijen P; van Alphen FPJ; van den Biggelaar M; Vanhoorelbeke K; Veyradier A; Coppo P; Reutelingsperger C; Nicolaes GAF; Männik A; Voorberg J
    Blood; 2021 May; 137(19):2694-2698. PubMed ID: 33544829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR.
    Sakai K; Kuwana M; Tanaka H; Hosomichi K; Hasegawa A; Uyama H; Nishio K; Omae T; Hishizawa M; Matsui M; Iwato K; Okamoto A; Okuhiro K; Yamashita Y; Itoh M; Kumekawa H; Takezako N; Kawano N; Matsukawa T; Sano H; Ohshiro K; Hayashi K; Ueda Y; Mushino T; Ogawa Y; Yamada Y; Murata M; Matsumoto M
    Blood; 2020 Jun; 135(26):2413-2419. PubMed ID: 32253422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A
    Iio R; Akiyama S; Mitsumoto K; Iwata Y; Okushima H; Shimada K; Ota N; Tomida K; Fushimi H; Shoji T; Matsumoto M; Hayashi T
    BMC Nephrol; 2020 Oct; 21(1):431. PubMed ID: 33046023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel recombinant glycosylphosphatidylinositol (GPI)-anchored ADAMTS13 and variants for assessment of anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura.
    Li D; Xiao J; Paessler M; Zheng XL
    Thromb Haemost; 2011 Nov; 106(5):947-58. PubMed ID: 21901237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Biomarkers in Patients with Thrombotic Thrombocytopenic Purpura Presenting with Large and Small Ischemic Stroke.
    Lin C; Memon R; Sui J; Zheng XL
    Cerebrovasc Dis Extra; 2021; 11(1):29-36. PubMed ID: 33601375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura.
    Laghmouchi A; Graça NAG; Voorberg J
    Front Immunol; 2021; 12():757192. PubMed ID: 34858410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura.
    Bendapudi PK; Foy BH; Mueller SB; Liu J; Feingold LM; Burke KE; Cruz W; Chen MY; Lau ES; Goldberg RL; Tatake I; Wilkinson SC; Carney BJ; Stone JR; Park D; Avelino AR; Hassan S; Andrzejewski C; Ruby KN; Friedman KD; Brunker PAR; Leaf RK; Higgins J; Dzik WH; Stefely JA; Makar RS
    N Engl J Med; 2024 May; 390(18):1690-1698. PubMed ID: 38718359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma Cell Directed Therapy for Immune Thrombotic Thrombocytopenic Purpura (iTTP).
    Chen M; Shortt J
    Transfus Med Rev; 2022 Oct; 36(4):204-214. PubMed ID: 36396570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura.
    Falter T; Rossmann H; de Waele L; Dekimpe C; von Auer C; Müller-Calleja N; Häuser F; Degreif A; Marandiuc D; Messmer X; Sprinzl M; Lackner KJ; Jurk K; Vanhoorelbeke K; Lämmle B
    Blood Adv; 2023 Sep; 7(17):5091-5102. PubMed ID: 37399489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-cardiac surgery thrombotic thrombocytopenic purpura: presence of anti-ADAMTS13 autoantibodies at preoperative baseline.
    Tordon B; Warkentin TE; Moore JC; Arnold DM
    Platelets; 2022 Apr; 33(3):479-483. PubMed ID: 33852372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of relapse and preventative strategies in immune thrombotic thrombocytopenic purpura.
    Pavenski K; Huang SS; Patriquin CJ
    Expert Rev Hematol; 2021 Nov; 14(11):1027-1040. PubMed ID: 34747320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers.
    Hrdinová J; D'Angelo S; Graça NAG; Ercig B; Vanhoorelbeke K; Veyradier A; Voorberg J; Coppo P
    Haematologica; 2018 Jul; 103(7):1099-1109. PubMed ID: 29674502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.
    Joly BS; Stepanian A; Leblanc T; Hajage D; Chambost H; Harambat J; Fouyssac F; Guigonis V; Leverger G; Ulinski T; Kwon T; Loirat C; Coppo P; Veyradier A;
    Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis of thrombotic thrombocytopenic purpura].
    Galstyan GM; Klebanova EE
    Ter Arkh; 2020 Dec; 92(12):207-217. PubMed ID: 33720596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges in the diagnosis of thrombotic thrombocytopenic purpura.
    Siniard RC; Gangaraju R; May JE; Marques MB
    Expert Rev Hematol; 2023; 16(11):861-869. PubMed ID: 37767808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.